An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein

Cell Host & Microbe
Stuart J D NeilPaul Bieniasz

Abstract

Type 1 interferon (IFN) inhibits the release of HIV-1 virus particles via poorly defined mechanisms. Here, we show that IFNalpha induces retention of viral particles on the surface of fibroblasts, T cells, or primary lymphocytes infected with HIV-1 lacking the Vpu protein. Retained particles are tethered to cell surfaces, can be endocytosed, appear fully assembled, exhibit mature morphology, and can be detached by protease. Strikingly, expression of the HIV-1 Vpu protein attenuates the ability of human cells to adhere to, and thereby retain, nascent HIV-1 particles upon IFNalpha treatment. Vpu also counteracts the IFNalpha-induced retention of virus-like particles assembled from the Ebola virus matrix protein. Furthermore, levels of IFNalpha that suppress replication of Vpu-defective HIV-1 have little effect on wild-type HIV-1. Thus, we propose that HIV-1 expresses Vpu to counteract an IFNalpha-induced, general host defense that inhibits dissemination of enveloped virions from the surface of infected cells.

References

Jan 1, 1991·Antimicrobial Agents and Chemotherapy·M S SmithJ S Pagano
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·H G GöttlingerW A Haseltine
Sep 2, 1988·Science·K StrebelM A Martin
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·H G GöttlingerW A Haseltine
Oct 5, 2001·Clinical Microbiology Reviews·C E Samuel
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dimiter G DemirovEric O Freed
Feb 20, 2002·European Journal of Clinical Investigation·N ChristeffM-L Gougeon
May 3, 2002·Reviews in Medical Virology·Ralf WagnerHans-Dieter Klenk
Apr 15, 2003·Journal of Virology·Uta K von SchwedlerWesley I Sundquist
Sep 23, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jay A LevyCarl Mackewicz
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Vasundhara VarthakaviPaul Spearman
May 14, 2004·Journal of Virology·Juan Martin-SerranoPaul D Bieniasz
Oct 22, 2004·Nature Immunology·Paul D Bieniasz
Dec 22, 2004·Molecular Cell·Stephen P Goff
Nov 18, 2005·Biochemical and Biophysical Research Communications·Kentaro AsaokaSatoshi Inoue
Jan 19, 2006·The Journal of Experimental Medicine·Gang PengSharon M Wahl
Jan 24, 2006·Biochemical and Biophysical Research Communications·Yuichi TanakaTsutomu Chiba
Jan 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Atsushi OkumuraPaula M Pitha
Sep 19, 2006·Immunity·Anette H H van Boxel-DezaireGeorge R Stark
Sep 19, 2006·Immunity·Daniel B Stetson, Ruslan Medzhitov
Dec 7, 2006·PLoS Biology·Nolwenn JouvenetPaul D Bieniasz

❮ Previous
Next ❯

Citations

Jan 12, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Björn D KuhlChen Liang
May 27, 2008·Nature·Nolwenn JouvenetSanford M Simon
Feb 6, 2010·Nature Medicine·Annika KühlStefan Pöhlmann
Feb 12, 2010·The New England Journal of Medicine·John Guatelli
Jan 31, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rachel L KaletskyPaul Bates
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Eri MiyagiKlaus Strebel
Oct 30, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ravindra K GuptaGreg J Towers
Oct 1, 2010·Proceedings of the National Academy of Sciences of the United States of America·Heidi L SchubertChristopher P Hill
Apr 12, 2012·The Journal of Biological Chemistry·Bastien MangeatVincent Piguet
Oct 9, 2012·The Journal of Biological Chemistry·Reuben S HarrisDavid T Evans
Nov 26, 2009·AIDS Research and Human Retroviruses·Andrey TokarevJohn Guatelli
Sep 17, 2011·DNA and Cell Biology·Sreeja SarojiniCarol Shoshkes Reiss
Aug 22, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Stuart Neil, Paul Bieniasz
Dec 21, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Amy Andrew, Klaus Strebel
Oct 19, 2011·The Journal of Infectious Diseases·Annika KühlStefan Pöhlmann
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Michael H Malim, Paul D Bieniasz
May 27, 2011·Journal of Virology·Kazuya ShiratoFumihiro Taguchi
Dec 19, 2008·Journal of Virology·Toshie SakumaJiro Yasuda
Dec 18, 2009·Journal of Virology·Giada MattiuzzoYasuhiro Takeuchi
Jan 7, 2011·Journal of Virology·Mark A YondolaPeter Palese
Nov 28, 2008·Journal of Virology·Nolwenn JouvenetPaul D Bieniasz
Aug 19, 2011·Journal of Virology·Stefanie HomannJohn Guatelli
Jul 16, 2008·Annual Review of Genetics·Daniel Wolf, Stephen P Goff
Aug 16, 2011·Physiology·Muthukumar Balasubramaniam, Eric O Freed
Sep 18, 2009·BMC Medicine·Klaus StrebelKuan-Teh Jeang
Apr 6, 2013·Retrovirology·Jerome A ZackDimitrios N Vatakis
Dec 24, 2010·Retrovirology·Mathieu DubéÉric A Cohen
Dec 28, 2010·Retrovirology·Björn D KuhlMark A Wainberg
Feb 20, 2010·Retrovirology·Su Jung YangPaula M Cannon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.